Efficacy and safety of direct oral anticoagulants in intermediate-high risk pulmonary embolism: results from a multidisciplinary multicenter prospective registry
Non-recommended dosing of direct oral anticoagulants in acute pulmonary embolism is related to an increased rate of adverse events at 6 months: results of a prospective regional multicenter registry